Domino synthesis of fused pyrazolo[5,1-b]quinazolin-9(1H)-ones catalyzed by CuI via subsequent Michael addition and elimination

[1]  Shengjie Yang,et al.  Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents. , 2014, European journal of medicinal chemistry.

[2]  D. Hu,et al.  Synthesis and anti-TMV activity of novel β-amino acid ester derivatives containing quinazoline and benzothiazole moieties. , 2014, Bioorganic & medicinal chemistry letters.

[3]  Xiao-guang Chen,et al.  A novel derivative of quinazoline, WYK431 induces G2/M phase arrest and apoptosis in human gastric cancer BGC823 cells through the PI3K/Akt pathway. , 2014, International journal of oncology.

[4]  Y. Mabkhot,et al.  Synthesis, Anti-microbial and Molecular Docking Studies of Quinazolin-4(3H)-one Derivatives , 2014, Molecules.

[5]  A. Alanazi,et al.  Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. , 2014, European journal of medicinal chemistry.

[6]  Xiang-Shan Wang,et al.  Copper(I)-catalyzed synthesis of 1-arylpyrazolo[5,1-b]quinazolin-9(1H)-one via intramolecular alkyne hydroamination , 2014 .

[7]  N. Kyprianou,et al.  Therapeutic value of quinazoline-based compounds in prostate cancer. , 2013, Anticancer research.

[8]  Victoria L. Paddock,et al.  Regiocontrolled synthesis of 3- and 5-aminopyrazoles, pyrazolo[3,4-d]pyrimidines, pyrazolo[3,4-b]pyridines and pyrazolo[3,4-b]quinolinones as MAPK inhibitors , 2013 .

[9]  V. Alagarsamy,et al.  Synthesis, Analgesic and Anti-inflammatory Activities of 3- Ethyl-2-substituted Amino-3H-quinazolin-4-ones , 2013 .

[10]  J. Eibl,et al.  Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro. , 2013, European journal of pharmacology.

[11]  Jun-qing Chen,et al.  Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents. , 2013, European journal of medicinal chemistry.

[12]  K. Abouzid,et al.  Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors. , 2013, European journal of medicinal chemistry.

[13]  Juan Tan,et al.  Design, synthesis and antiviral activity of novel quinazolinones. , 2012, European journal of medicinal chemistry.

[14]  Hengshan Wang,et al.  PTSA-catalyzed Mannich-type-cyclization-oxidation tandem reactions: one-pot synthesis of 1,3,5-substituted pyrazoles from aldehydes, hydrazines and alkynes. , 2012, Organic & biomolecular chemistry.

[15]  W. Greenlee,et al.  Pyrazoloquinolines as PDE10A inhibitors: discovery of a tool compound. , 2012, Bioorganic & medicinal chemistry letters.

[16]  N. Fujii,et al.  Gold-catalyzed three-component annulation: efficient synthesis of highly functionalized dihydropyrazoles from alkynes, hydrazines, and aldehydes or ketones. , 2012, Organic letters.

[17]  Pradip Maity,et al.  Catalytic synthesis of nonracemic azaproline derivatives by cyclization of β-alkynyl hydrazines under kinetic resolution conditions. , 2011, Angewandte Chemie.

[18]  Y. A. Ibrahim,et al.  Stereoselective synthesis of dihydrothiadiazinoazines and dihydrothiadiazinoazoles and their pyrolytic desulfurization ring contraction , 2011 .

[19]  Y. Lou,et al.  Anti-tumor effects of B-2, a novel 2,3-disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazoline derivative, on the human lung adenocarcinoma A549 cell line in vitro and in vivo. , 2011, Chemico-biological interactions.

[20]  Ke-Fang Yang,et al.  Combinatorial synthesis of 3-arylideneaminoquinazolin-4(1H)-one derivatives catalyzed by iodine in ionic liquids. , 2011, ACS combinatorial science.

[21]  Ke-Fang Yang,et al.  Facile method for the combinatorial synthesis of 2,2-disubstituted quinazolin-4(1H)-one derivatives catalyzed by iodine in ionic liquids. , 2010, Journal of combinatorial chemistry.

[22]  Y. A. Ibrahim,et al.  Pyrolytic desulfurization ring contraction of condensed thiadiazines as a general route towards pyrazoloazines and pyrazoloazoles with a bridgehead (ring junction) nitrogen atom , 2008 .

[23]  V. N. Chernenko,et al.  Tuning of chemo- and regioselectivities in multicomponent condensations of 5-aminopyrazoles, dimedone, and aldehydes. , 2008, The Journal of organic chemistry.

[24]  Lawrence C Kuo,et al.  Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[25]  V. Thiéry,et al.  Synthesis of novel 2,3-substituted quinazolin-4-ones by condensation of alkyl or aromatic diamines with 5-(N-arylimino)-4-chloro-5H-1,2,3-dithiazoles , 2007 .

[26]  S. Shiba,et al.  Synthesis of some new pyrazoloquinazolinone and quinazolinone derivatives , 2006 .

[27]  E. Erba,et al.  Single step synthesis of 2,3-dialkyl-6-nitro-quinazolin-4(3H)-imines and 3,5-dialkyl-9-nitro-imidazo[1,2-c]quinazolin-2(3H)-ones , 2005 .

[28]  Krystal J Alligood,et al.  A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) , 2004, Cancer Research.

[29]  Xianjin Yang,et al.  The reaction of 2-(1-hydropolyfluoro-1-alkenyl)-4H-3,1-benzoxin-4-ones with dinucleophilic reagents: a convenient route to fluoroalkylated nitrogen-containing tricyclic compounds , 2004 .

[30]  I. Black,et al.  Differential Involvement of Metabotropic and p75 Neurotrophin Receptors in Effects of Nerve Growth Factor and Neurotrophin‐3 on Cultured Purkinje Cell Survival , 1998, Journal of neurochemistry.

[31]  W. Denny,et al.  Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of binding. , 1997, Journal of medicinal chemistry.

[32]  W. Denny,et al.  Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. , 1996, Journal of medicinal chemistry.

[33]  R. Davis,et al.  PD 90780, a non peptide inhibitor of nerve growth factor's binding to the P75 NGF receptor. , 1995, Biochemical and biophysical research communications.

[34]  J. E. Hayes,et al.  Reactions of azines. 12. Preparation and reactions of triphenyl[2-([phenyl(methoxycarbonyl)methylene]hydrazono)propyl]phosphonium bromide , 1987 .

[35]  J. Sircar,et al.  Reactions of 2H‐3,1‐benzoxazine‐2,4‐(1H)dione (isatoic anhydride) with anions of 1,4‐dihydro‐5H‐pyrazol‐5‐ones: Synthesis of pyrazolo[5,1‐b]quinazolin‐9‐ones , 1981 .